A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People
Clinical trial NCT06139315 · COMPLETED
Trial details
- NCT number
- NCT06139315
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2023-06-07
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.